Literature DB >> 25396186

Comparison of the complications in vertical rectus abdominis musculocutaneous flap with non-reconstructed cases after pelvic exenteration.

Heechang Jeon1, Eul Sik Yoon1, Hi-Jin You1, Hyon-Surk Kim1, Byung-Il Lee1, Seung Ha Park1.   

Abstract

BACKGROUND: Perineal reconstruction following pelvic exenteration is a challenging area in plastic surgery. Its advantages include preventing complications by obliterating the pelvic dead space and minimizing the scar by using the previous abdominal incision and a vertical rectus abdominis musculocutaneous (VRAM) flap. However, only a few studies have compared the complications and the outcomes following pelvic exenteration between cases with and without a VRAM flap. In this study, we aimed to compare the complications and the outcomes following pelvic exenteration with or without VRAM flap coverage.
METHODS: We retrospectively reviewed the cases of nine patients for whom transpelvic VRAM flaps were created following pelvic exenteration due to pelvic malignancy. The complications and outcomes in these patients were compared with those of another nine patients who did not undergo such reconstruction.
RESULTS: Flap reconstruction was successful in eight cases, with minor complications such as wound infection and dehiscence. In all cases in the reconstructed group (n=9), structural integrity was maintained and major complications including bowel obstruction and infection were prevented by obliterating the pelvic dead space. In contrast, in the control group (n=9), peritonitis and bowel obstruction occurred in 1 case (11%).
CONCLUSIONS: Despite the possibility of flap failure and minor complications, a VRAM flap can result in adequate perineal reconstruction to prevent major complications of pelvic exenteration.

Entities:  

Keywords:  Musculocutaneous flap; Pelvic exenteration; Rectus abdominis

Year:  2014        PMID: 25396186      PMCID: PMC4228216          DOI: 10.5999/aps.2014.41.6.722

Source DB:  PubMed          Journal:  Arch Plast Surg        ISSN: 2234-6163


  12 in total

1.  A rectus abdominis myocutaneous flap to reconstruct abdominal wall defects.

Authors:  S J Mathes; J Bostwick
Journal:  Br J Plast Surg       Date:  1977-10

2.  Reconstruction of pelvic exenterative wounds with transpelvic rectus abdominis flaps: a case series.

Authors:  A K Jain; A J DeFranzo; M W Marks; B W Loggie; S Lentz
Journal:  Ann Plast Surg       Date:  1997-02       Impact factor: 1.539

3.  The rectus abdominis flap for perineal wounds.

Authors:  H S Shukla; L E Hughes
Journal:  Ann R Coll Surg Engl       Date:  1984-09       Impact factor: 1.891

4.  Perineal perforator-based island flaps: the next frontier in perineal reconstruction.

Authors:  Jeong Tae Kim; Samuel Yew Ming Ho; Jin Hee Hwang; Jang Hyun Lee
Journal:  Plast Reconstr Surg       Date:  2014-05       Impact factor: 4.730

5.  Gracilis myocutaneous vaginal reconstruction.

Authors:  P M Heath; J E Woods; K C Podratz; P G Arnold; G B Irons
Journal:  Mayo Clin Proc       Date:  1984-01       Impact factor: 7.616

6.  Gastrointestinal complications associated with pelvic exenteration.

Authors:  J W Orr; H M Shingleton; K D Hatch; P T Taylor; E E Partridge; S J Soong
Journal:  Am J Obstet Gynecol       Date:  1983-02-01       Impact factor: 8.661

7.  Coverage of the infected wound.

Authors:  S J Mathes; L J Feng; T K Hunt
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

8.  The comprehensive complication index: a novel continuous scale to measure surgical morbidity.

Authors:  Ksenija Slankamenac; Rolf Graf; Jeffrey Barkun; Milo A Puhan; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2013-07       Impact factor: 12.969

9.  Silicone implant to prevent visceral damage during adjuvant radiotherapy for retroperitoneal sarcoma.

Authors:  A B Ball; A Cassoni; R M Watkins; J M Thomas
Journal:  Br J Radiol       Date:  1990-05       Impact factor: 3.039

10.  Pelvic exenteration: factors associated with major surgical morbidity.

Authors:  J T Soper; A Berchuck; W T Creasman; D L Clarke-Pearson
Journal:  Gynecol Oncol       Date:  1989-10       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.